Overexpressions of Vimentin and Integrins in Human Metastatic Spine Tumors |
Park, Sung Bae
(Department of Neurosurgery, Seoul National University Boramae Medical Center)
Ryu, Young-Joon (Department of Pathology, Kangwon National University School of Medicine) Chung, Young Seob (Department of Neurosurgery, Seoul National University Boramae Medical Center) Kim, Chi Heon (Department of Neurosurgery, Seoul National University College of Medicine) Chung, Chun Kee (Department of Neurosurgery, Seoul National University College of Medicine) |
1 | Clezardin P : Integrins in bone metastasis formation and potential therapeutic implications. Curr Cancer Drug Targets 9 : 801-806, 2009 DOI |
2 | Coghlin C, Murray GI : Current and emerging concepts in tumour metastasis. J Pathol 222 : 1-15, 2010 DOI |
3 | Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, et al. : Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 12 : 99-107, 2001 |
4 | Engebraaten O, Trikha M, Juell S, Garman-Vik S, Fodstad O : Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins. Anticancer Res 29 : 131-137, 2009 |
5 | Gudadze M, Kankava K, Mariamidze A, Burkadze G : Distribution of cancer stem cells in ductal invasive carcinoma of breast (review). Georgian Med News (222) : 44-50, 2013 |
6 | Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M : Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 261 : 12665-12674, 1986 |
7 | Ivaska J : Vimentin : central hub in EMT induction? Small GTPases 2 : 51-53, 2011 DOI |
8 | Mallini P, Lennard T, Kirby J, Meeson A : Epithelial-to-mesenchymal transition : what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev 40 : 341-348, 2014 DOI |
9 | Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS : Mechanisms of cancer cell metastasis to the bone : a multistep process. Future Oncol 7 : 1285-1297, 2011 DOI |
10 | Qin J, Vinogradova O, Plow EF : Integrin bidirectional signaling : a molecular view. PLoS Biol 2 : e169, 2004 DOI |
11 | Roodman GD : Mechanisms of bone metastasis. Discov Med 4 : 144-148, 2004 |
12 | Schneider JG, Amend SR, Weilbaecher KN : Integrins and bone metastasis : integrating tumor cell and stromal cell interactions. Bone 48 : 54-65, 2011 DOI |
13 | Sethi S, Macoska J, Chen W, Sarkar FH : Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res 3 : 90-99, 2010 |
14 | Tsuji T, Ibaragi S, Hu GF : Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69 : 7135-7139, 2009 DOI |
15 |
Shen Z, Ye Y, Kauttu T, Seppanen H, Vainionpaa S, Wang S, et al. : Novel focal adhesion protein kindlin-2 promotes the invasion of gastric cancer cells through phosphorylation of integrin |
16 | Sterling JA, Edwards JR, Martin TJ, Mundy GR : Advances in the biology of bone metastasis : how the skeleton affects tumor behavior. Bone 48 : 6-15, 2011 DOI |
17 | Tsai JH, Yang J : Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27 : 2192-2206, 2013 DOI |
18 |
van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G : Integrin |
19 |
van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, et al. : Targeting of |
20 | van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Lowik C : Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction : elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Miner Res 16 : 1077-1091, 2001 DOI |
21 | Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, et al. : Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30 : 1436-1448, 2011 DOI |
22 | Zhao Y, Bachelier R, Treilleux I, Pujuguet P, Peyruchaud O, Baron R, et al. : Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67 : 5821-5830, 2007 DOI |
23 | Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, et al. : Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol 139 : 739-746, 2013 DOI |
24 | Yoneda T : Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci 5 : 75-81, 2000 DOI |
25 | Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS : Cancer statistics in Korea : incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45 : 1-14, 2013 DOI |
26 | Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK, et al. : Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 8 : R20, 2006 DOI |
27 | van der Pluijm G : Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone 48 : 37-43, 2011 DOI |
![]() |